Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Bloomberg now reporting: following BP and Shells decision to reduce/withdraw from Russian Oil activities, EXXON (our Neighbour in Wyoming fields) now has a dilema whether to make an announcement.
Can only bode well for COPL if RS confirm or better our 1.5b - 1.9b figures, as EXXON is virtually onsite (well, next door anyway) abd this may nudge them into action?
MOSCOW (Reuters) - The Russian central bank has ordered market players to reject foreign clients' bids to sell Russian securities from 0400 GMT on Monday, according to a central bank document seen by Reuters.
(Ref: POLY -CleverThoughts)
Cant believe that the Oil Price (circa $100 and rising) is now UP 33% since our RNS announcement on 10/Jan, and yet this EXTRA $25 has not impacted on our SP for Current Drilling or Future Plans.
This SP is just bumping back and forth between 30p - 38p.
Would love RS to announce we got our Discovery figure wrong - its FAR BIGGER than we thought !!!
Unfortunately I dont see Brockham ever happening.
Locals are totally against Angus and this OIl Field.
For new investors look at Paul Vonk on you Tube to see the lies we investors were told (Star Wars trilogy etc) and the previous arguments the council had with us.
Line 21 - Primer Design: PROmate®COVID-19 2G 2
Approved 11/Feb
so X/sheet not updated for nearly 4 weeks, now includes 14 more approvals
https://www.gov.uk/government/publications/covid-19-test-validation-approved-products#history
"The protocol has been issued to address the serious public health risk any potential shortage of supply may cause. Supply of tests listed in the protocol annex must cease within 10 working days if the test fails validation.
RNS 26/11/21:
As announced on 2 November 2021, the Company submitted 11 products for review under the CTDA to meet the original submission deadline of 1 September 2021. Further to the validation of its genesig® COVID-19 test, Novacyt's Primerdesign Ltd PROmate® COVID-19 test (encompassing both the PROmate® 1 Gene q16 and q32 products) remains on the temporary protocol and continues to be supplied to the NHS under the PHE National Microbiology Framework. The Company awaits updates on the additional eight products submitted to the CTDA across its COVID-19 testing portfolioThe protocol will expire on 28 February 2022."
Does this mean that the 8 applications outstanding will be Good to Go after this date?
+ Font forget (from RNS 10/Jan)
" Production has already commenced from the Dakota Fm, the lowermost reservoir sand in the BFU 14-30VF discovery well (100% WI) at 100-120 Bbl. oil/d"
So an update to this Small but Important start would be appreciated = Revenue $8,000 - $9,600 per DAY before Costs
https://www.gov.uk/government/publications/covid-19-test-validation-approved-products#full-publication-update-history
Awaiting 7/8 Approvals
Just wondering if this is still happening, NO updates since 20th January, and with all restrictions lifted and an End of month deadline is it still relevant?
This protocol is valid from 1 November 2021 until the end of 28 February 2022.